Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis

Title
Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 7, Issue 7, Pages 415-420
Publisher
Springer Nature
Online
2010-04-20
DOI
10.1038/nrclinonc.2010.40

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started